Buy Attruby (acoramidis)

What is Attruby (acoramidis) for?

Attruby (acoramidis) is a prescription treatment for cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults ^[1].

Attruby (acoramidis) is available as tablets (356 mg) ^[1].

How does Attruby (acoramidis) work?

Attruby (acoramidis) works by stabilizing a protein called transthyretin (TTR). It binds to specific sites on TTR, preventing the protein from breaking apart into smaller pieces, which is the first step in forming harmful amyloid deposits. This helps slow or stop the process of amyloid buildup linked to certain diseases ^[1].

Where has Attruby (acoramidis) been approved?

Attruby (acoramidis) is currently approved in the USA ^[2].

References:

1. Highlights of prescribing information, Accessdata.fda.gov, Accessed 16 January 2025.
2. FDA approves drug for heart disorder caused by transthyretin-mediated amyloidosis. FDA.gov, Accessed 16 January 2025.